Cargando…
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review
A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be use...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907879/ https://www.ncbi.nlm.nih.gov/pubmed/36755270 http://dx.doi.org/10.1186/s40560-023-00654-7 |
_version_ | 1784884263990067200 |
---|---|
author | Alessandri, Francesco Di Nardo, Matteo Ramanathan, Kollengode Brodie, Daniel MacLaren, Graeme |
author_facet | Alessandri, Francesco Di Nardo, Matteo Ramanathan, Kollengode Brodie, Daniel MacLaren, Graeme |
author_sort | Alessandri, Francesco |
collection | PubMed |
description | A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of ventilator-induced lung injury and provide lung rest while awaiting recovery. The mortality of COVID-19-related ARDS was variously reassessed during the pandemic. Veno-venous (VV) ECMO was the default choice to manage refractory respiratory failure; however, with concomitant severe right ventricular dysfunction, venoarterial (VA) ECMO or mechanical right ventricular assist devices with extracorporeal gas exchange (Oxy-RVAD) were also considered. ECMO has also been used to manage special populations such as pregnant women, pediatric patients affected by severe forms of COVID-19, and, in cases with persistent and seemingly irreversible respiratory failure, as a bridge to successful lung transplantation. In this narrative review, we outline and summarize the most recent evidence that has emerged on ECMO use in different patient populations with COVID-19-related ARDS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40560-023-00654-7. |
format | Online Article Text |
id | pubmed-9907879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99078792023-02-09 Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review Alessandri, Francesco Di Nardo, Matteo Ramanathan, Kollengode Brodie, Daniel MacLaren, Graeme J Intensive Care Review A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of ventilator-induced lung injury and provide lung rest while awaiting recovery. The mortality of COVID-19-related ARDS was variously reassessed during the pandemic. Veno-venous (VV) ECMO was the default choice to manage refractory respiratory failure; however, with concomitant severe right ventricular dysfunction, venoarterial (VA) ECMO or mechanical right ventricular assist devices with extracorporeal gas exchange (Oxy-RVAD) were also considered. ECMO has also been used to manage special populations such as pregnant women, pediatric patients affected by severe forms of COVID-19, and, in cases with persistent and seemingly irreversible respiratory failure, as a bridge to successful lung transplantation. In this narrative review, we outline and summarize the most recent evidence that has emerged on ECMO use in different patient populations with COVID-19-related ARDS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40560-023-00654-7. BioMed Central 2023-02-08 /pmc/articles/PMC9907879/ /pubmed/36755270 http://dx.doi.org/10.1186/s40560-023-00654-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Alessandri, Francesco Di Nardo, Matteo Ramanathan, Kollengode Brodie, Daniel MacLaren, Graeme Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title | Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title_full | Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title_fullStr | Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title_full_unstemmed | Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title_short | Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
title_sort | extracorporeal membrane oxygenation for covid-19-related acute respiratory distress syndrome: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907879/ https://www.ncbi.nlm.nih.gov/pubmed/36755270 http://dx.doi.org/10.1186/s40560-023-00654-7 |
work_keys_str_mv | AT alessandrifrancesco extracorporealmembraneoxygenationforcovid19relatedacuterespiratorydistresssyndromeanarrativereview AT dinardomatteo extracorporealmembraneoxygenationforcovid19relatedacuterespiratorydistresssyndromeanarrativereview AT ramanathankollengode extracorporealmembraneoxygenationforcovid19relatedacuterespiratorydistresssyndromeanarrativereview AT brodiedaniel extracorporealmembraneoxygenationforcovid19relatedacuterespiratorydistresssyndromeanarrativereview AT maclarengraeme extracorporealmembraneoxygenationforcovid19relatedacuterespiratorydistresssyndromeanarrativereview |